Joseph Oliveto

Joseph Oliveto

Chief Executive Officer & PresidentatMilestone Pharmaceuticals· In proxies 2022–2025

Pay in FY2024-55% from the year before · Milestone Pharmaceuticals stock +41.3% the same year

Joseph Oliveto was paid $882.3K in FY2024 (Dec), down 55%. Milestone Pharmaceuticals stock rose 41.3% that year.

Pay$100 in the stock at the end of FY21 → $36
Pay is from the Summary Compensation Table of each Milestone Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Milestone PharmaceuticalsPublic company · 4 yr
    • Chief Executive Officer & President2022 – Present · 4 yrStock in role -89%
  2. Chelsea Therapeutics International (Nasdaq: CHTPPublic company · 13 yr
    • Director2013 – Present · 13 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?